Eli Lilly

When fees are better

While annual cards are costlier than normal lifetime free cards, they have many additional benefits. Such a situation results in a lot of cost saving, as intense competition inevitably results in a situation where a similar...

powered by

FDA OKs Abilify for autism-linked irritability

PRINCETON, N.J. - The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday.

powered by

VerifyNow(R) System Highlighted In POPular Study Comparing Platelet Reactivity Tests

Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 Test was one of multiple methods evaluated in the POPular...

powered by

Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research...

67 WALL STREET, New York - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. Traditional Chinese Medicine VS. Western...

powered by

Sonoco Named One of the 25 Top Companies for Leaders in North America by Hewitt Associates, The...

HARTSVILLE, S.C.----Sonoco , one of the largest diversified global packaging companies, has been named a North America Top Company for Leaders by Hewitt Associates, announced Cindy Hartley, senior vice president, Human Resources.

powered by

Trading Review for Vivus Inc. Issued by Beacon Equity (GlobeNewswire)

DALLAS -- BeaconEquity.com announces an investment report featuring biopharmaceutical company Vivus Inc. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an...

powered by

This Baby Is a Nice Addition (at Motley Fool)

Today, the drugmaker received a positive opinion from the EU's Committee for Medicinal Products for Human Use (CHMP) for its fertility treatment Elonva. The drug works just as well at helping women get pregnant as its currently...

powered by

Analyst Choice Initiates Market Analysis on Healthcare, Technology and Consumer Goods Sectors

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC). NEW DELHI, INDIA--(Marketwire - November 20, 2009) - Despite weakness in the U.S. dollar, stocks spent nearly the entire session...

powered by

After Re-Engineering Itself, Verdezyne Sets Course to Develop Biofuels and “Green” Industrial...

After Carlsbad, CA-based Verdezyne disclosed last month that it plans to raise more than $15 million in venture funding, I arranged to sit down with Damien Perriman, the company’s vice president of business development. As it...

powered by

Why Pharma Doesn't Twitter

The FDA has so far failed to craft rules clarifying how companies can participate in online discussions Some 60% of Americans say that when they need medical information, they turn to the Internet. Those tweets had a common...

powered by
1 2 3 4 5 next »